3849 studies found for:    "Slow Virus Diseases"
Show Display Options
Rank Status Study
1 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
2 Recruiting Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
Condition: Acute HIV Infection
Interventions: Drug: cART(TDF/AZT+3TC+LPV/r);   Procedure: CTL infusion
3 Completed GW873140 to Treat HIV-1 Infected Adults
Condition: HIV Infections
Intervention: Drug: GW873140
4 Completed Prevalence and Determinants of Chronic Obstructive Pulmonary Disease (COPD) in HIV+ Patients
Conditions: HIV Infections;   COPD
Intervention:
5 Completed HIV Maintenance Therapy With T-20 During HAART Interruption
Condition: HIV Infection
Intervention: Drug: T-20
6 Completed A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection
Condition: HIV Infections
Intervention: Drug: CD4 Antigens
7 Completed Experimental Design of Couple Counseling and Testing in Antenatal Clinics in Dar es Salaam, Tanzania
Condition: HIV Infections
Interventions: Behavioral: Couples VCT;   Behavioral: Individual VCT
8 Completed A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient
Condition: HIV Infections
Interventions: Drug: Nelfinavir mesylate;   Drug: Levocarnitine;   Drug: Adefovir dipivoxil;   Drug: Saquinavir;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine
9 Completed Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine)
Condition: HIV Infections
Interventions: Drug: placebo vaginal ring;   Drug: TMC120 (dapivirine) vaginal ring
10 Completed An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C
Conditions: HIV Infection;   Hepatitis C
Interventions: Drug: nelfinavir 1,250 mg twice daily;   Drug: Zidovudine 300 mg twice daily;   Drug: Lamivudine 150 mg twice daily
11 Completed A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow Transplant
Conditions: Lymphoma, Non-Hodgkin;   HIV Infections
Intervention: Drug: Zidovudine
12 Completed Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection
Condition: HIV Infections
Intervention:
13 Completed
Has Results
Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM)
Conditions: HIV Infections;   Depression
Interventions: Drug: Bupropion;   Drug: Placebo
14 Completed
Has Results
Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.
Conditions: HIV Infections;   HSV-2 Genital Herpes
Intervention: Drug: 3% SPL7013 Gel (VivaGel)
15 Completed Brief Introductory Therapy for Opioid Dependence
Conditions: Opiate Dependence;   HIV Infections
Interventions: Behavioral: Standard drug counseling;   Behavioral: BDRC
16 Completed Efficacy of Elevated CD4 Counts on CMV Retinitis
Conditions: Acquired Immunodeficiency Syndrome;   Cytomegalovirus Retinitis
Intervention:
17 Unknown  Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection
Conditions: Cytomegalovirus Retinitis;   HIV Infections
Intervention: Drug: Valganciclovir
18 Completed C2P - Phase III: MPowerment and Community Promise
Condition: HIV Infections
Interventions: Behavioral: Printed materials;   Behavioral: Peer advocates
19 Completed Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults
Condition: HIV Infections
Interventions: Biological: pGA2/JS7 DNA;   Biological: Modified vaccinia Ankara/HIV62
20 Completed A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols
Conditions: Pneumonia, Pneumocystis Carinii;   HIV Infections
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years